Multifunctional Hybrid Membrane-Coated Nanomotors for Magnetically Guided, Cascade-Activated Chemoimmunotherapy for Triple-Negative Breast Cancer
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Here, we report a multifunctional hybrid membrane-coated nanomotor for cancer chemoimmunotherapy, which consists of mesoporous silica-coated iron oxide nanoparticles (MF) as a drug carrier, loaded with doxorubicin (DOX), l -arginine ( l -arg), and glucose oxidase (GOx), and camouflaged with a hybrid of red blood cell membranes (mRBC) and cancer cell membranes (CCM). RM-GDL-MF has a cascade of catalytic reactions, where glucose is catalyzed by GOx to produce H 2 O 2, and l -arg is oxidized by the produced H 2 O 2 to release nitric oxide (NO), leading to self-propelled motion in order to promote the penetration of the extracellular matrix (ECM) in the tumor. The hybrid membrane provides not only stealth properties from mRBC to evade immune clearance but also tumor-orientation ability to target the tumor from the CCM. The generation of reactive oxygen species (ROS) was demonstrated to induce immunogenic cell death (ICD), thereby enhancing antitumor immune responses through the recruitment of CD8 + tumor-infiltrating lymphocytes (TILs), promotion of dendritic cell maturation, and reprogramming of macrophages toward the proinflammatory M1 phenotype. In vitro and in vivo experiments demonstrated that RM/R4-GDL-MF had significant tumor accumulation efficiency and antitumor efficacy. This multimodal nanomotor shows great potential for effectively treating tumors.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Micro and Nano Robotics · Molecular Communication and Nanonetworks · Photoreceptor and optogenetics research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry
The Chinese University of Hong Kong
College of Life Science
Hunan Normal University
School of Biomedical Sciences
Hong Kong Hub of Paediatric Excellence (HK HOPE)
Funding
Research Grants Council, University Grants Committee · Science and Technology Program of Hunan Province · National Natural Science Foundation of China · Chinese University of Hong Kong
References (30)
Show source-provided references
1. Cancer. 2025 https://www.who.int/news-room/fact-sheets/detail/cancer. (accessed January 27, 2025).
2. 10.4172/2161-1041.S2-00110.4172/2161-1041.S2-001 ↗
3. 10.3390/cancers1317428710.3390/cancers13174287 ↗
4. 10.1002/cncr.3066710.1002/cncr.30667 ↗
5. 10.3389/fphar.2018.0025910.3389/fphar.2018.00259 ↗
6. 10.1093/nsr/nwx06210.1093/nsr/nwx062 ↗
7. 10.1002/adhm.20200119610.1002/adhm.202001196 ↗
8. 10.1002/adfm.20210779110.1002/adfm.202107791 ↗
9. 10.1002/adfm.20180773310.1002/adfm.201807733 ↗
10. 10.1002/smll.20200648410.1002/smll.202006484 ↗
11. 10.1021/acs.nanolett.3c0177510.1021/acs.nanolett.3c01775 ↗
12. 10.1146/annurev-immunol-032713-12014210.1146/annurev-immunol-032713-120142 ↗
13. Glinsky V. V. · Cancer Res. · 2003 · 63 · 3805
14. 10.1038/s41571-022-00699-x10.1038/s41571-022-00699-x ↗
15. 10.1021/acsnano.7b0835510.1021/acsnano.7b08355 ↗
16. 10.1002/adfm.20180629010.1002/adfm.201806290 ↗
17. 10.1002/adma.20241222710.1002/adma.202412227 ↗
18. 10.1039/C6CC09169E10.1039/C6CC09169E ↗
19. 10.1038/s41467-019-08670-810.1038/s41467-019-08670-8 ↗
20. 10.1039/D1BM01184G10.1039/D1BM01184G ↗
21. 10.1021/jacs.1c0307110.1021/jacs.1c03071 ↗
22. 10.1002/advs.20200252510.1002/advs.202002525 ↗
23. 10.1038/s41467-023-36650-610.1038/s41467-023-36650-6 ↗
24. 10.1002/smll.20230343810.1002/smll.202303438 ↗
25. 10.1021/acsnano.1c0789310.1021/acsnano.1c07893 ↗
26. 10.1002/adma.20241273010.1002/adma.202412730 ↗
27. 10.1002/adma.20250033710.1002/adma.202500337 ↗
28. 10.1021/acsnano.4c0122910.1021/acsnano.4c01229 ↗
29. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
30. 10.1038/cddis.2013.35010.1038/cddis.2013.350 ↗